Abstract
Gastric cancer is one of the most common malignant tumors. Over recent years, the development of new genetic technologies have built the foundation for a better understanding of the abnormal expression of miRNAs in gastric cancer. It might improve the accuracy of prognosis prediction and lead to more efficient personalized treatments for gastric cancer. The article will review the potential applications of miRNAs as biomarkers for mechanism, diagnosis and prognosis of gastric cancer. Key words: Stomach neoplasms; MicroRNA; Tumor markers, biological; Diagnosis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
